TechForce Robotics Advances Pharmaceutical Automation Initiative Through Phase 2 Deployment of PUR-E at SAPU Bio OEB-5 Sterile Injectable cGMP Facility

▤ Summary

TechForce Robotics expanded its pharmaceutical automation initiative by deploying PUR-E inside SAPU Bio’s OEB-5 sterile injectable cGMP facility. The deployment builds on Phase 1 work with LIM-E and now extends into clean room and sterile manufacturing operations. TechForce and Oncotelic are using the rollout to evaluate robotics, automation, and future electronic batch record opportunities in a regulated environment. The press release also frames TechForce’s RaaS model as a subscription service that includes deployment, support, training, and ongoing management.

▦ Linked Companies